These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9117567)

  • 1. Neurotransmitter receptor/G-protein mediated signal transduction in Alzheimer's disease brain.
    Cowburn RF; Fowler CJ; O'Neill C
    Neurodegeneration; 1996 Dec; 5(4):483-8. PubMed ID: 9117567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease.
    Cowburn RF; Fowler CJ; O'Neill C
    Acta Neurol Scand Suppl; 1996; 165():25-32. PubMed ID: 8740986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-G-protein signalling in Alzheimer's disease.
    Cowburn RF; O'Neill C; Bonkale WL; Ohm TG; Fastbom J
    Biochem Soc Symp; 2001; (67):163-75. PubMed ID: 11447833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function and amount of GTP binding proteins in postmortem human brain in dementia of the Alzheimer's type].
    Hashimoto E; Ozawa H; Saito T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):105-9. PubMed ID: 8042344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease.
    Fowler CJ; O'Neill C; Winblad B; Cowburn RF
    Acta Neurol Scand Suppl; 1992; 139():59-62. PubMed ID: 1357909
    [No Abstract]   [Full Text] [Related]  

  • 6. G-protein coupled signal transduction systems in the Alzheimer's disease brain.
    O'Neill C; Fowler CJ; Winblad B; Cowburn RF
    Biochem Soc Trans; 1994 Feb; 22(1):167-71. PubMed ID: 8206216
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain.
    Bergström L; Garlind A; Nilsson L; Alafuzoff I; Fowler CJ; Winblad B; Cowburn RF
    J Neurol Sci; 1991 Oct; 105(2):225-33. PubMed ID: 1684616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients.
    Wang HY; Friedman E
    Neurosci Lett; 1994 May; 173(1-2):37-9. PubMed ID: 7936419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine muscarinic M2 receptor stimulated [35S]GTP gamma S binding shows regional selective changes in Alzheimer's disease postmortem brain.
    Cowburn RF; Wiehager B; Ravid R; Winblad B
    Neurodegeneration; 1996 Mar; 5(1):19-26. PubMed ID: 8731378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Gi-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease.
    Cowburn RF; O'Neill C; Ravid R; Winblad B; Fowler CJ
    Neurosci Lett; 1992 Jul; 141(1):16-20. PubMed ID: 1508395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.
    Greenwood AF; Powers RE; Jope RS
    Neuroscience; 1995 Nov; 69(1):125-38. PubMed ID: 8637611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activity.
    Bonkale WL; Fastbom J; Wiehager B; Ravid R; Winblad B; Cowburn RF
    Brain Res; 1996 Oct; 737(1-2):155-61. PubMed ID: 8930361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
    O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
    Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin signal transduction in hamster brain: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein.
    Carlson LL; Weaver DR; Reppert SM
    Endocrinology; 1989 Nov; 125(5):2670-6. PubMed ID: 2551662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain.
    Li X; Greenwood AF; Powers R; Jope RS
    Neurobiol Aging; 1996; 17(1):115-22. PubMed ID: 8786793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances in signal transduction mechanisms in Alzheimer's disease.
    Fowler CJ; Cowburn RF; Garlind A; Winblad B; O'Neill C
    Mol Cell Biochem; 1995; 149-150():287-92. PubMed ID: 8569742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein coupling of receptors to ionic channels and other effector systems.
    Birnbaumer L; Yatani A; VanDongen AM; Graf R; Codina J; Okabe K; Mattera R; Brown AM
    Soc Gen Physiol Ser; 1990; 45():169-83. PubMed ID: 1696032
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease.
    Cowburn RF; Fowler CJ; Garlind A; Alafuzoff I; Nilsson L; Winblad B; Bergström L
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):748-9. PubMed ID: 1658238
    [No Abstract]   [Full Text] [Related]  

  • 19. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging.
    Roth GS; Joseph JA; Mason RP
    Trends Neurosci; 1995 May; 18(5):203-6. PubMed ID: 7610488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's disease.
    Crews FT; Kurian P; Freund G
    Life Sci; 1994; 55(25-26):1993-2002. PubMed ID: 7997058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.